Text Size

The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Assaf-Harofeh Medical Center.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Apos Medical and Sports Technology Ltd.
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT01266382
First received: December 22, 2010
Last updated: December 23, 2010
Last verified: July 2009
History of Changes
  Purpose

The purpose of the study is to examine the effect of a new biomechanical device and treatment methodology (AposTherapy) on gait patterns, pain, function and quality of life of patients with musculoskeletal and neurological disorders. Based on previous reports the investigators hypothesis that this therapy will have a positive effect on these measurements.


Condition Intervention
Osteoarthritis
Spinal Diseases
Ligament Rupture
Lower Extremity Fracture
Neurological Disorders
 Device: AposTherapy

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Assaf-Harofeh Medical Center:

Primary Outcome Measures:
  • Spatio-temporal Gait parameters [ Designated as safety issue: No ]
  • WOMAC [ Designated as safety issue: No ]
  • SF-36 [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • FAOS questionnaire
  • Oswestry questionnaire
  • Clinical measurements

Intervention Details:
    Device: AposTherapy
    a biomechanical device including 2 hemispheric biomechanical elements attached to a platform in a form of a shoe. the biomechanical device is calibrated to each patient by a physiotherapist specialized with the treatment methodology. patient are instructed to walk indoor with the device. time of exercise is gradually increase
  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Primary osteoarthritis
  • Lower limb joint replacement
  • Lower limbs fractures
  • Spinal disorders including LBP w/wo refered symptoms, radiculopathy, spinal stenosis
  • ligaments tear
  • Meniscal tears

Exclusion Criteria:

  • lack of balance (3 falls in the last year)
  • incapable to complete a questionnaire •>age 85
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01266382

Contacts
Contact: Ganit Segal, MA ganitm@apos.co.il

Locations
Israel
AposTherapy center Recruiting
Herzliya, Israel, 46733
Contact: Ganit Segal         ganitm@apos.co.il    
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Apos Medical and Sports Technology Ltd.
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01266382     History of Changes
Other Study ID Numbers: 93/09
Study First Received: December 22, 2010
Last Updated: December 23, 2010
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Nervous System Diseases
Osteoarthritis
Spinal Diseases
Rupture
Arthritis
 Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Bone Diseases
Wounds and Injuries

ClinicalTrials.gov processed this record on June 18, 2013